AbSci raises $5.1 mln
AbSci said April 25 that it raised $5.1 million in Series A financing led by Phoenix Venture Partners. Portland, Oregon-based AbSci provides a protein expression platform for use in biopharmaceutical manufacturing.
26 April 2016•3 mins read
